Control of Cellular Bcl-xL Levels by Deamidation-Regulated Degradation

PLoS Biology

Volumn 11, Issue 6, 2013, Pages

  Dho, So Hee ^a,b   Deverman, Benjamin E ^a,g   Lapid, Carlo ^c   Manson, Scott R ^a   Gan, Lu ^a   Riehm, Jacob J ^a   Aurora, Rajeev ^d   Kwon, Ki Sun ^b   Weintraub, Steven J ^a,e,f  

^a Washington University in St Louis School of Medicine   (United States)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c WASHINGTON UNIVERSITY   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; ASPARTIC ACID; CALPAIN; CISPLATIN; CYCLOHEXIMIDE; ETOPOSIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DEAMINATION; EMBRYO; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING;

AMIDES; AMINO ACID SEQUENCE; ANIMALS; BCL-X PROTEIN; CALPAIN; CELL LINE; CONSERVED SEQUENCE; DNA DAMAGE; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS;

METAZOA;

EID: 84879397353     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001588     Document Type: Article

References (78)

1. Youle RJ, Strasser A, (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59.
2. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN, (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4: 327-332.
3. Adams JM, Cory S, (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337.
4. Friess H, Lu Z, Andren-Sandberg A, Berberat P, Zimmermann A, et al. (1998) Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer. Ann Surg 228: 780-787.
5. Martinez-Brocca MA, Castilla C, Navarro E, Amaya MJ, Travado P, et al. (2008) Clinicopathological correlations of Bcl-xL and Bax expression in differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 68: 190-197.
6. Zhao WL, Daneshpouy ME, Mounier N, Briere J, Leboeuf C, et al. (2004) Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood 103: 695-697.
7. Materna V, Surowiak P, Markwitz E, Spaczynski M, Drag-Zalesinska M, et al. (2007) Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients. Oncol Rep 17: 505-516.
8. Williams J, Lucas PC, Griffith KA, Choi M, Fogoros S, et al. (2005) Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease. Gynecol Oncol 96: 287-295.
9. Watanabe J, Kushihata F, Honda K, Sugita A, Tateishi N, et al. (2004) Prognostic significance of Bcl-xL in human hepatocellular carcinoma. Surgery 135: 604-612.
10. Castilla C, Congregado B, Chinchon D, Torrubia FJ, Japon MA, et al. (2006) Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. Endocrinology 147: 4960-4967.
11. Aebersold DM, Kollar A, Beer KT, Laissue J, Greiner RH, et al. (2001) Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation. Int J Cancer 96: 41-54.
12. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, et al. (2000) An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 60: 6101-6110.
13. Minn AJ, Rudin CM, Boise LH, Thompson CB, (1995) Expression of bcl-xL can confer a multidrug resistance phenotype. Blood 86: 1903-1910.
14. Shoemaker AR, Oleksijew A, Bauch J, Belli BA, Borre T, et al. (2006) A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo. Cancer Res 66: 8731-8739.
15. Littlejohn JE, Cao X, Miller SD, Ozvaran MK, Jupiter D, et al. (2008) Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts. Int J Cancer 123: 202-208.
16. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, et al. (2002) Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111: 51-62.
17. Henderson CC, Zhang Z, Manson SR, Riehm JJ, Kataoka M, et al. (2005) A moderate reduction of Bcl-x(L) expression protects against tumorigenesis; however, it also increases susceptibility to tissue injury. Oncogene 24: 7120-7124.
18. Zhang H, Taylor J, Luther D, Johnston J, Murray S, et al. (2003) Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis. J Pharmacol Exp Ther 307: 24-33.
19. de la Coste A, Fabre M, McDonell N, Porteu A, Gilgenkrantz H, et al. (1999) Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol 277: G702-G708.
20. Kamimukai N, Togo S, Hasegawa S, Kubota T, Kurosawa H, et al. (2001) Expression of Bcl-2 family reduces apoptotic hepatocytes after excessive hepatectomy. Eur Surg Res 33: 8-15.
21. Tzung SP, Fausto N, Hockenbery DM, (1997) Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 150: 1985-1995.
22. Iravani S, Zhang HQ, Yuan ZQ, Cheng JQ, Karl RC, et al. (2003) Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasia. Hum Pathol 34: 975-982.
23. Zhao R, Yang FT, Alexander DR, (2004) An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation. Cancer Cell 5: 37-49.
24. Chang CY, Lin YM, Lee WP, Hsu HH, Chen EI, (2006) Involvement of Bcl-X(L) deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells. Oncogene 25: 2656-2665.
25. Robinson NE, Robinson AB, (2001) Prediction of protein deamidation rates from primary and three-dimensional structure. Proc Natl Acad Sci U S A 98: 4367-4372.
26. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341.
27. Bryson K, McGuffin LJ, Marsden RL, Ward JJ, Sodhi JS, et al. (2005) Protein structure prediction servers at University College London. Nucleic Acids Res 33: W36-W38.
28. Cuff JA, Clamp ME, Siddiqui AS, Finlay M, Barton GJ, (1998) JPred: a consensus secondary structure prediction server. Bioinformatics 14: 892-893.
29. Blaineau SV, Aouacheria A, (2009) BCL2DB: moving 'helix-bundled' BCL-2 family members to their database. Apoptosis: An International Journal on Programmed Cell Death 14: 923-925.
30. Bailey TL, Williams N, Misleh C, Li WW, (2006) MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Research 34: W369-W373.
31. Hertz GZ, Stormo GD, (1999) Identifying DNA and protein patterns with statistically significant alignments of multiple sequences. Bioinformatics 15: 563-577.
32. Bailey TL, (2002) Discovering novel sequence motifs with MEME. Curr Protoc Bioinformatics Chapter 2: Unit 2 4.
33. Robinson NE, Robinson ZW, Robinson BR, Robinson AL, Robinson JA, et al. (2004) Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. The Journal of Peptide Research 63: 426-436.
34. Zhao R, Follows GA, Beer PA, Scott LM, Huntly BJ, et al. (2008) Inhibition of the Bcl-xL deamidation pathway in myeloproliferative disorders. N Engl J Med 359: 2778-2789.
35. Takehara T, Takahashi H, (2003) Suppression of Bcl-xL deamidation in human hepatocellular carcinomas. Cancer Res 63: 3054-3057.
36. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, et al. (2003) Erratum to: Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 115: 503.
37. Zhao R, Oxley D, Smith TS, Follows GA, Green AR, et al. (2006) DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH. PLoS Biol 5: e1 doi:10.1371/journal.pbio.0050001.
38. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB, (1997) Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. Embo J 16: 968-977.
39. Aritomi M, Kunishima N, Inohara N, Ishibashi Y, Ohta S, et al. (1997) Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-2 protein family. J Biol Chem 272: 27886-27892.
40. Lo SC, Hannink M, (2006) PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J Biol Chem 281: 37893-37903.
41. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, et al. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014.
42. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, et al. (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590.
43. Schuler M, Maurer U, Goldstein JC, Breitenbucher F, Hoffarth S, et al. (2003) p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ 10: 451-460.
44. Minn AJ, Kettlun CS, Liang H, Kelekar A, Vander Heiden MG, et al. (1999) Bcl-xL regulates apoptosis by heterodimerization-dependent and-independent mechanisms. EMBO J 18: 632-643.
45. Minn AJ, Velez P, Schendel SL, Liang H, Muchmore SW, et al. (1997) Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 385: 353-357.
46. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB, (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637.
47. Koury MJ, Koury ST, Kopsombut P, Bondurant MC, (2005) In vitro maturation of nascent reticulocytes to erythrocytes. Blood 105: 2168-2174.
48. Cimmino A, Capasso R, Muller F, Sambri I, Masella L, et al. (2008) Protein isoaspartate methyltransferase prevents apoptosis induced by oxidative stress in endothelial cells: role of Bcl-Xl deamidation and methylation. PLoS One 3: e3258 doi:10.1371/journal.pone.0003258.
49. Rechsteiner M, Rogers SW, (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21: 267-271.
50. Rogers S, Wells R, Rechsteiner M, (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368.
51. Thorsness PE, Koshland DE Jr, (1987) Inactivation of isocitrate dehydrogenase by phosphorylation is mediated by the negative charge of the phosphate. J Biol Chem 262: 10422-10425.
52. Liu Z, Wang S, Zhou H, Yang Y, Zhang M, (2009) Na+/H+ exchanger mediates TNF-alpha-induced hepatocyte apoptosis via the calpain-dependent degradation of Bcl-xL. J Gastroenterol Hepatol 24: 879-885.
53. Nakagawa T, Yuan J, (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150: 887-894.
54. Gil-Parrado S, Fernandez-Montalvan A, Assfalg-Machleidt I, Popp O, Bestvater F, et al. (2002) Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem 277: 27217-27226.
55. Martinez LO, Agerholm-Larsen B, Wang N, Chen W, Tall AR, (2003) Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 278: 37368-37374.
56. Shumway SD, Maki M, Miyamoto S, (1999) The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J Biol Chem 274: 30874-30881.
57. Wang N, Chen W, Linsel-Nitschke P, Martinez LO, Agerholm-Larsen B, et al. (2003) A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 111: 99-107.
58. Fujita N, Nagahashi A, Nagashima K, Rokudai S, Tsuruo T, (1998) Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene 17: 1295-1304.
59. Tan Y, Wu C, De Veyra T, Greer PA, (2006) Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 281: 17689-17698.
60. Gottlieb RA, Nordberg J, Skowronski E, Babior BM, (1996) Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci U S A 93: 654-658.
61. Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC, (2000) Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol 2: 318-325.
62. Zhu WH, Loh TT, (1995) Effects of Na+/H+ antiport and intracellular pH in the regulation of HL-60 cell apoptosis. Biochim Biophys Acta 1269: 122-128.
63. Grenier AL, Abu-ihweij K, Zhang G, Ruppert SM, Boohaker R, et al. (2008) Apoptosis-induced alkalinization by the Na+/H+ exchanger isoform 1 is mediated through phosphorylation of amino acids Ser726 and Ser729. Am J Physiol Cell Physiol 295: C883-896.
64. Tsao N, Lei HY, (1996) Activation of the Na(+)/H(+) antiporter, Na+/HCO3(-)/CO3(2-) cotransporter, or Cl(-)/HCO3(-) exchanger in spontaneous thymocyte apoptosis. J Immunol 157: 1107-1116.
65. Dai HY, Tsao N, Leung WC, Lei HY, (1998) Increase of intracellular pH in p53-dependent apoptosis of thymocytes induced by gamma radiation. Radiat Res 150: 183-189.
66. Khaled AR, Moor AN, Li A, Kim K, Ferris DK, et al. (2001) Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol Cell Biol 21: 7545-7557.
67. Huc L, Sparfel L, Rissel M, Dimanche-Boitrel MT, Guillouzo A, et al. (2004) Identification of Na+/H+ exchange as a new target for toxic polycyclic aromatic hydrocarbons. Faseb J 18: 344-346.
68. Robinson NE, (2002) Protein deamidation. Proc Natl Acad Sci U S A 99: 5283-5288.
69. Flatmark T, Sletten K, (1968) Multiple forms of cytochrome c in the rat. Precursor-product relationship between the main component Cy I and the minor components Cy II and Cy III in vivo. J Biol Chem 243: 1623-1629.
70. Watanabe A, Takio K, Ihara Y, (1999) Deamidation and isoaspartate formation in smeared tau in paired helical filaments. Unusual properties of the microtubule-binding domain of tau. J Biol Chem 274: 7368-7378.
71. Takemoto L, Emmons T, Granstrom D, (1990) The sequences of two peptides from cataract lenses suggest they arise by deamidation. Curr Eye Res 9: 793-797.
72. Reissner KJ, Aswad DW, (2003) Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell Mol Life Sci 60: 1281-1295.
73. Elledge SJ, Winston J, Harper JW, (1996) A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol 6: 388-392.
74. Robinson AB, Rudd CJ, (1974) Deamidation of glutaminyl and asparaginyl residues in peptides and proteins. Curr Top Cell Regul 8: 247-295.
75. Wong JT, (1975) A co-evolution theory of the genetic code. Proc Natl Acad Sci U S A 72: 1909-1912.
76. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, et al. (2011) CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Research 39: D225-D229.
77. Hu X, Cherbas L, Cherbas P, (2003) Transcription activation by the ecdysone receptor (EcR/USP): identification of activation functions. Mol Endocrinol 17: 716-731.
78. Rice P, Longden I, Bleasby A, (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16: 276-277.